| UniProt/SwissProt ID: | EF2_HUMAN |
| Description: | eukaryotic translation elongation factor 2 [Source:HGNC Symbol;Acc:3214] |
| Location: | chr19 p13.3 |
| Node attribute: | substrate |
|
| Position | PhosphoPeptide | Catalytic kinase | Source |
|---|
| S500 | RVMKFsVSPVV | | PhosphoSitePlus |
| T435 | MGPNYtPGKKE | GTP_EFTU_D2 | PhosphoSitePlus; SysPTM |
| Y373 | RCELLyEGPPD | | PhosphoSitePlus; HPRD |
| S623 | DKGEVsARQEL | | HPRD |
| T779 | SQVAGtPMFVV | EFG_C | PhosphoSitePlus |
| S623 | DKGEVsARQEL | EFG_IV | PhosphoSitePlus |
| T724 | GQIIPtARRCL | EFG_IV | PhosphoSitePlus |
| T404 | SKMVPtSDKGR | | PhosphoSitePlus |
| T57 | GETRFtDTRKD | | HPRD; phosphoELM; RegPhos; SysPTM |
| T724 | GQIIPtARRCL | | HPRD |
| S72 | CITIKsTAISL | GTP_EFTU | PhosphoSitePlus |
| T54 | ARAGEtRFTDT | EEF2K | HPRD; SysPTM |
| Y79 | AISLFyELSEN | GTP_EFTU | PhosphoSitePlus |
| S502 | MKFSVsPVVRV | | PhosphoSitePlus; HPRD; phosphoELM; RegPhos; SysPTM |
| T59 | TRFTDtRKDEQ | | HPRD; phosphoELM; RegPhos; SysPTM |
| Y434 | IMGPNyTPGKK | GTP_EFTU_D2 | PhosphoSitePlus |
| T54 | ARAGEtRFTDT | GTP_EFTU | PhosphoSitePlus; SysPTM |
| T59 | TRFTDtRKDEQ | EEF2K | HPRD; SysPTM |
| S76 | KSTAIsLFYEL | GTP_EFTU | PhosphoSitePlus |
| T57 | GETRFtDTRKD | eEF2K | RegPhos; SysPTM |
| Y760 | VVGGIyGVLNR | EFG_C | PhosphoSitePlus |
| T59 | TRFTDtRKDEQ | eEF2K | RegPhos; SysPTM |
| Y579 | DPVVSyRETVS | | PhosphoSitePlus |
| Y265 | LWGDRyFDPAN | | RegPhos |
| Y443 | KKEDLyLKPIQ | | HPRD |
| S197 | YGEGEsGPMGN | GTP_EFTU | PhosphoSitePlus |
| S399 | LMMYIsKMVPT | | PhosphoSitePlus; HPRD |
| T54 | ARAGEtRFTDT | eEF2K | RegPhos; SysPTM |
| T73 | ITIKStAISLF | GTP_EFTU | PhosphoSitePlus |
| T54 | ARAGEtRFTDT | | phosphoELM; RegPhos; SysPTM |
| Y411 | DKGRFyAFGRV | GTP_EFTU_D2 | PhosphoSitePlus |
| Y175 | EPEELyQTFQR | GTP_EFTU | PhosphoSitePlus |
| S48 | AGIIAsARAGE | | HPRD |
| T435 | MGPNYtPGKKE | | HPRD; SysPTM |
| Y443 | KKEDLyLKPIQ | GTP_EFTU_D2 | PhosphoSitePlus |
| Y730 | ARRCLyASVLT | EFG_IV | PhosphoSitePlus |
| T59 | TRFTDtRKDEQ | GTP_EFTU | PhosphoSitePlus; SysPTM |
| T57 | GETRFtDTRKD | EEF2K | HPRD; SysPTM |
| T57 | GETRFtDTRKD | GTP_EFTU | PhosphoSitePlus; SysPTM |
|
| Position | PhosphoPeptide | Catalytic kinase | Source |
|---|
| T59 | GETRFTDtRKDEQER | PPP2CA | HPRD |
| T57 | RAGETRFtDTRKDEQ | PPP2CA | HPRD |
| T57 | RAGETRFtDTRKDEQ | PPM1A | HPRD |
|
| Ensembl ID | Variation | Source | Cancer name | Pubmed |
|---|
| ENSP00000307940 | A508V | COSMIC | Skin Cancer | 21984974 |
| ENSP00000307940 | R633H | COSMIC | Head and Neck Cancer | 21798893 |
| ENSP00000307940 | V137L | COSMIC | Head and Neck Cancer | 21798893 |
|
| Ensembl ID | Cancer name | Design | Sample | Change | Ratio | Pubmed |
|---|
| ENSP00000307940 | Prostate Cancer | Treatment (none vs. bicalutamide treatment) | cell line | Up | 1.5 | 17152098 |
| ENSP00000307940 | Prostate Cancer | Treatment (none vs. bicalutamide treatment) | cell line | Up | 1.9 | 17152098 |
| ENSP00000307940 | Prostate Cancer | Treatment (none vs. bicalutamide treatment) | cell line | Up | 2.4 | 17152098 |
| ENSP00000307940 | Prostate Cancer | Treatment (none vs. bicalutamide treatment) | cell line | Up | 2.7 | 17152098 |
| ENSP00000307940 | Uterine Cancer | Normal vs. Cancer | tissue | Up | | 17902640 |
| ENSP00000307940 | Leukemia | Normal vs. Cancer | cell line | Down | 0.34 | 17022645 |
| ENSP00000307940 | Leukemia | Normal vs. Cancer | cell line | Down | 0.34 | 17022645 |
| ENSP00000307940 | Oral Premalignant Lesions | Normal vs. Cancer | tissue | Up | 1.3 | 19072117 |
| ENSP00000307940 | Oral Premalignant Lesions | Normal vs. Cancer | tissue | Up | 1.5 | 19072117 |
| ENSP00000307940 | Oral Premalignant Lesions | Normal vs. Cancer | tissue | Up | 1.4 | 19072117 |
| ENSP00000307940 | Oral Premalignant Lesions | Normal vs. Cancer | tissue | Up | 1.3 | 19072117 |
| ENSP00000307940 | Breast Cancer | Treatment (none vs. 17b-Estradiol treatment) | cell line | Up | 2.2 | 18491314 |
| ENSP00000307940 | hepatitis B virus | Normal vs. Cancer | tissue | Up | 2.9 | 14654528 |
| ENSP00000307940 | hepatitis C virus | Normal vs. Cancer | tissue | Up | 2.9 | 14654528 |
| ENSP00000307940 | Hepatocellular Carcinoma | Normal vs. Cancer | tissue | Up | 2.9 | 14654528 |
| ENSP00000307940 | Hepatocellular Carcinoma | Cancer vs. Cancer (HCC vs. HuCCA) | cell line | Up | | 20069059 |
| ENSP00000307940 | Lung Cancer | Cancer vs. Cancer | cell line | Down | | 17284061 |
| ENSP00000307940 | Gastric Cancer | Treatment (none vs. Vincristine-resistant) | cell line | Down | 0.42 | 18253933 |
| ENSP00000307940 | Breast Cancer | Normal vs. Cancer | tissue | Up | 6.2 | 20005186 |
| ENSP00000307940 | Breast Cancer | Normal vs. Cancer | cell line | Up | 1.6 | 20052998 |
| ENSP00000307940 | Breast Cancer | Normal vs. Cancer | cell line | Up | 1.1 | 20052998 |
| ENSP00000307940 | Breast Cancer | Metastasis | cell line | Down | 0.68 | 20052998 |
| ENSP00000307940 | Breast Cancer | Cancer vs. Cancer (Non-TNBC vs. TNBC) | cell line | Up | | 20596302 |
| ENSP00000307940 | Renal Cancer | Normal vs. Cancer | tissue | Up | 0.8-11.4 | 12923786 |
| ENSP00000307940 | Ovarian Cancer | Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) | cell line | Up | 1.7 | 19714814 |
| ENSP00000307940 | Ovarian Cancer | Treatment (Paclitaxel-sensitive vs. Paclitaxel-resistant) | cell line | Up | 2.1 | 19714814 |
| ENSP00000307940 | Gastric Cancer | Treatment (none vs. drug-resistant) | cell line | Up | 1.4 | 20625496 |
| ENSP00000307940 | Gastric Cancer | Normal vs. Cancer | tissue | Down | 0.45 | 15761955 |
| ENSP00000307940 | Gastric Cancer | Normal vs. Cancer | tissue | Down | 0.5 | 15761955 |
| ENSP00000307940 | Pancreatic Cancer | Treatment (Gemcitabine-sensitive vs. Gemcitabine-resistant) | cell line | Up | 1.6 | 20944110 |
| ENSP00000307940 | Pancreatic Cancer | Treatment (Gemcitabine-sensitive vs. Gemcitabine-resistant) | cell line | Up | 3.1 | 20944110 |
|
| EF2_HUMAN do not have hyperphosphorylation site. |
|
EF2_HUMAN is not in KEGG pathway.
|
|
| GO ID | GO_Term | Evidence | Ontology |
|---|
| GO:0006412 | translation | TAS | biological_process |
| GO:0006414 | translational elongation | TAS | biological_process |
| GO:0044267 | cellular protein metabolic process | TAS | biological_process |
| GO:0005829 | cytosol | TAS | cellular_component |
| GO:0003924 | GTPase activity | IEA | molecular_function |
| GO:0006414 | translational elongation | IEA | biological_process |
| GO:0030529 | ribonucleoprotein complex | IDA | cellular_component |
| GO:0003746 | translation elongation factor activity | IEA | molecular_function |
| GO:0010467 | gene expression | TAS | biological_process |
| GO:0006184 | GTP catabolic process | IEA | biological_process |
| GO:0005525 | GTP binding | IEA | molecular_function |
| GO:0005515 | protein binding | IEA | molecular_function |
| GO:0005844 | polysome | IEA | cellular_component |
|
Fatal error: Uncaught Error: Call to undefined function mysql_close() in /usr/local/apache/htdocs/PhoSigNet/include/locateconfig.inc.php:23
Stack trace:
#0 /usr/local/apache/htdocs/PhoSigNet/proteintable.php(435): db_disconnect(Object(mysqli))
#1 {main}
thrown in
/usr/local/apache/htdocs/PhoSigNet/include/locateconfig.inc.php on line
23